Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Inhibition of CHK1 Enhances Cell Death Induced By the Bcl-2-Selective Inhibitor ABT-199 in Acute Myeloid Leukemia Cells

Jianyun Zhao, Xiaojia Niu, Holly Edwards, Yue Wang, Jeffrey W Taub, MD, Hai Lin, Yubin Ge, PhD

Blood (2015) 126 (23): 2469.

https://doi.org/10.1182/blood.V126.23.2469.2469

Published: 2015

Journal Articles

Epidemiology and Outcomes of Respiratory Virus Infections in Adult Acute Leukemia and Hematopoietic Stem Cell Transplant Patients

Gaurav Trikha, MBBS, MD, Rebecca Conway, BSN, John W Hiemenz, MD, Per T. Ljungman, MD PhD

Blood (2014) 124 (21): 4984.

https://doi.org/10.1182/blood.V124.21.4984.4984

Published: 2014

Journal Articles

A Novel Method of Using Molecular Profiling in Myelodysplastic Syndromes to Predict Patient-Specific Potential Therapeutics

Christopher R. Cogle, MD, Gaurav Trikha, MBBS, MD, Peter P. Sayeski, PhD, Shireen Vali, PhD, Ansu Kumar, Neeraj Kumar Singh, Prashant R Nair, Deepak Anil Lala, Kabya Basu, Taher Abbasi, MS, Maher Albitar, MD

Blood (2014) 124 (21): 5591.

https://doi.org/10.1182/blood.V124.21.5591.5591

Published: 2014

Journal Articles

Downregulation Of Deoxycytidine Kinase In Cytarabine-Resistant Mantle Cell Lymphoma Cells Confers Cross-Resistance To Nucleoside Analogs Fludarabine, Gemcitabine and Cladribine, But Not To Other Classes Of Anti-Lymphoma Agents

Magdalena Klanova, Lucie Lorkova, MSc, Ondrej Vit, MSc, Bokang Maswabi, MD, Jan Molinsky, MD, Jana Pospisilova, MSc, Cory Mavis, BSc, MSc, Francisco Hernandez, MD, Martin Vokurka, MD, PhD, Jiri Petrak, MSc, PhD, Pavel Klener, Jr., MD, PhD

Blood (2013) 122 (21): 3835.

https://doi.org/10.1182/blood.V122.21.3835.3835

Published: 2013

Journal Articles

Ixazomib, An Investigational Orally Bioavailable Proteasome Inhibitor, Increases p21 Expression Inducing Caspase-Dependent Cell Death, Cell-Cycle Arrest, and In B-Cell Lymphoma Pre-Clinical Models

Cory Mavis, BSc, MSc, Juan Gu, PhD, Joseph Skitzki, MD, Francisco Hernandez, MD, Myron S. Czuczman, MD

Blood (2013) 122 (21): 1828.

https://doi.org/10.1182/blood.V122.21.1828.1828

Published: 2013

Journal Articles

Inhibition Of Cdk2 Promotes The Generation Of Inducible CD8 + T Regulatory Cells By Modulating The Epigenetic Regulator EZH2

Lequn Li, MD, PhD, Nikolaos Patsoukis, PhD, Anoma Nellore, MD, Vassiliki A. Boussiotis, MD, PhD

Blood (2013) 122 (21): 138.

https://doi.org/10.1182/blood.V122.21.138.138

Published: 2013

Journal Articles

Platelet Factor 4 (PF4) Causes Cell Cycle Arrest in Megakaryocytes (Megs) by Inactivating CDC2 (CDK1) and CDK2

Liqing Xiao, PhD, Mortimer Poncz, MD, Michele Lambert, MD

Blood (2012) 120 (21): 1238.

https://doi.org/10.1182/blood.V120.21.1238.1238

Published: 2012

Journal Articles

Anti-Myeloma Activity of LDC-000067, a Novel Selective Inhibitor of Cyclin Dependent Kinase 9: A Targeted Approach

Kathrin Niepoth, Dirk Gustavus, Doris Wenning, Michael Meisterernst, Joachim Kienast, Wolfgang E. Berdel, Guido Bisping

Blood (2011) 118 (21): 5110.

https://doi.org/10.1182/blood.V118.21.5110.5110

Published: 2011

Journal Articles

Roscovitine Sensitizes Leukemia and Lymphoma Cells to TRAIL-Induced Apoptosis and Enhances Cell-Mediated Cytotoxicity

Jan Molinsky, Marie Markova, Magdalena Klanova, Michal Koc, Lenka Beranova, Ladislav Andera, Zdenka Ludvikova, Martina Bohmova, Zdenka Gasova, Marek Trneny, Emanuel Necas, Jan Zivny, Pavel Klener

Blood (2010) 116 (21): 596.

https://doi.org/10.1182/blood.V116.21.596.596

Published: 2010

Journal Articles

Modulation of Multiple Myeloma Apoptosis and Adhesion by Seliciclib, A Selective Inhibitor of Cyclin Dependent Kinase (CDK)

Liat Josefsberg Ben-Yehuda, Michal Samookh, Arnon Nagler, M.D.

Blood (2010) 116 (21): 3971.

https://doi.org/10.1182/blood.V116.21.3971.3971

Published: 2010

Journal Articles

A Novel Pro-Survival Function of Cyclin-D1 Underlies Its Oncogenic Role and Potential as a Therapeutic Target In Mantle Cell Lymphoma

Elena Beltran, PhD, Vicente Fresquet, PhD, Javier Martinez-Useros, Jose A. Richter-Larrea, PhD, Ainara Sagardoy, PhD, Izaskun Sesma, Luciana L. Almada, PhD, Santiago Montes-Moreno, MD, Stefan Gesk, MD, Reiner Siebert, Prof., Dr., med., MaJose Calasanz, PhD, Felipe Prosper, MD, Miguel A. Piris, MD, Martin E. Fernandez-Zapico, MD, Jose A Martinez-Climent, MD, PhD

Blood (2010) 116 (21): 769.

https://doi.org/10.1182/blood.V116.21.769.769

Published: 2010

Journal Articles

Usefulness of Differential Scanning Calorimetry for Monitoring Ex Vivo the Changes In Responses of CLL Cells to Anti-Cancer Drugs: Development of Personalized Therapy

Malgorzata Rogalinska, Jerzy Blonski, Pawel Goralski, Oxana Komina, Arleta Kazmierczuk, Ewa Wawrzyniak, Aleksandra Kotkowska, Pawel Robak, Henryk Piekarski, Tadeusz Robak, Zofia Kilianska, Jozefa Wesierska-Gadek

Blood (2010) 116 (21): 4635.

https://doi.org/10.1182/blood.V116.21.4635.4635

Published: 2010

Journal Articles

CYC065, a Potent Derivative of Seliciclib Is Active In Multiple Myeloma In Preclinical Studies

Samantha Pozzi, MD, Diana Cirstea, M.D., Loredana Santo, MD, Doris M Nabikejje, Kishan Patel, Kathryn M Luly, Gaurav Gharti-Chhetry, Sonia Vallet, MD, Homare Eda, MD, PhD, Teru Hideshima, MD, Simon R Green, Kenneth C. Anderson, MD, David T. Scadden, MD, Noopur Raje, MD

Blood (2010) 116 (21): 2999.

https://doi.org/10.1182/blood.V116.21.2999.2999

Published: 2010

Journal Articles

Targeting CDK9 Dramatically Potentiates ABT-737-Induced Apoptosis in Human Multiple Myeloma Cells through a Bim-Dependent Mechanism.

Yun Dai, MD, PhD., Shuang Chen, MD, PhD, Xin-Yan Pei, MD, Viswanathan Ramakrishnan, Ph.D, Michael Wang, MD, MS., Robert Orlowski, PhD, Paul Dent, PhD, Steven Grant, MD

Blood (2009) 114 (22): 297.

https://doi.org/10.1182/blood.V114.22.297.297

Published: 2009

Journal Articles

Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia

Rong Chen, William G. Wierda, Sherri Chubb, Rachael E. Hawtin, Judith A. Fox, Michael J. Keating, Varsha Gandhi, William Plunkett

Blood (2009) 113 (19): 4637–4645.

https://doi.org/10.1182/blood-2008-12-190256

Published: 2009

Journal Articles

Gene Expression and Proteomic Profiling Predict Therapeutic Response to ABT-737 in Human and Mouse Models of Mantle Cell Lymphoma

Elena Beltran, MSc, Vicente Fresquet, PhD, Jose A Richter, MSc, Miguel A. Piris, MD, Reiner Siebert, MD, Jose A. Martinez-Climent, MD, PhD

Blood (2008) 112 (11): 608.

https://doi.org/10.1182/blood.V112.11.608.608

Published: 2008

Journal Articles

Dichotomy in NF-κb Signaling and Chemoresistance in IgV H Mutated Versus Unmutated CLL Cells Revealed by CD40Ligand/CpG Stimulation

Jacqueline Tromp, Sanne H. Tonino, Marinus H.J. Van Oers, MD, PhD, Eric Eldering

Blood (2008) 112 (11): 542.

https://doi.org/10.1182/blood.V112.11.542.542

Published: 2008

Journal Articles

Acquired Resistance to Tumor Necrosis Factor-Related Apoptosis- Inducing Ligand (TRAIL): Histone Deacetylase Inhibitors Resensitize TRAIL-Resistant Jurkat Acute Lymphocytic Leukemia Cells

Pavel Klener, Jr., Jan Molinsky, Tereza Simonova, Emanuel Necas, Ladislav Andera, Jan Zivny

Blood (2008) 112 (11): 5032.

https://doi.org/10.1182/blood.V112.11.5032.5032

Published: 2008

Journal Articles

Roscovitine Prevents Alloreactive T Cell Expansion and TNF-a-Mediated Proinflammatory Gene Expression and Protects against GvHD.

Lequn Li, MD, PhD, Hui Wang, MD, PhD, Roderick Bronson, MD, Vassiliki Boussiotis, MD, PhD

Blood (2008) 112 (11): 2341.

https://doi.org/10.1182/blood.V112.11.2341.2341

Published: 2008

Journal Articles

Bidirectional Control of Transcription Factor GATA2 and Cyclin/Cdks in Hematopoietic Cells.

Naoko Minegishi, MD, PhD, Hideo Harigae, M.D., Masayuki Yamamoto, MD, PhD

Blood (2008) 112 (11): 1382.

https://doi.org/10.1182/blood.V112.11.1382.1382

Published: 2008

NARROW

Inhibition of CHK1 Enhances Cell Death Induced By the Bcl-2-Selective Inhibitor ABT-199 in Acute Myeloid Leukemia Cells

Epidemiology and Outcomes of Respiratory Virus Infections in Adult Acute Leukemia and Hematopoietic Stem Cell Transplant Patients

A Novel Method of Using Molecular Profiling in Myelodysplastic Syndromes to Predict Patient-Specific Potential Therapeutics

Downregulation Of Deoxycytidine Kinase In Cytarabine-Resistant Mantle Cell Lymphoma Cells Confers Cross-Resistance To Nucleoside Analogs Fludarabine, Gemcitabine and Cladribine, But Not To Other Classes Of Anti-Lymphoma Agents

Ixazomib, An Investigational Orally Bioavailable Proteasome Inhibitor, Increases p21 Expression Inducing Caspase-Dependent Cell Death, Cell-Cycle Arrest, and In B-Cell Lymphoma Pre-Clinical Models

Inhibition Of Cdk2 Promotes The Generation Of Inducible CD8 + T Regulatory Cells By Modulating The Epigenetic Regulator EZH2

Platelet Factor 4 (PF4) Causes Cell Cycle Arrest in Megakaryocytes (Megs) by Inactivating CDC2 (CDK1) and CDK2

Anti-Myeloma Activity of LDC-000067, a Novel Selective Inhibitor of Cyclin Dependent Kinase 9: A Targeted Approach

Roscovitine Sensitizes Leukemia and Lymphoma Cells to TRAIL-Induced Apoptosis and Enhances Cell-Mediated Cytotoxicity

Modulation of Multiple Myeloma Apoptosis and Adhesion by Seliciclib, A Selective Inhibitor of Cyclin Dependent Kinase (CDK)

A Novel Pro-Survival Function of Cyclin-D1 Underlies Its Oncogenic Role and Potential as a Therapeutic Target In Mantle Cell Lymphoma

Usefulness of Differential Scanning Calorimetry for Monitoring Ex Vivo the Changes In Responses of CLL Cells to Anti-Cancer Drugs: Development of Personalized Therapy

CYC065, a Potent Derivative of Seliciclib Is Active In Multiple Myeloma In Preclinical Studies

Targeting CDK9 Dramatically Potentiates ABT-737-Induced Apoptosis in Human Multiple Myeloma Cells through a Bim-Dependent Mechanism.

Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia

Gene Expression and Proteomic Profiling Predict Therapeutic Response to ABT-737 in Human and Mouse Models of Mantle Cell Lymphoma

Dichotomy in NF-κb Signaling and Chemoresistance in IgV H Mutated Versus Unmutated CLL Cells Revealed by CD40Ligand/CpG Stimulation

Acquired Resistance to Tumor Necrosis Factor-Related Apoptosis- Inducing Ligand (TRAIL): Histone Deacetylase Inhibitors Resensitize TRAIL-Resistant Jurkat Acute Lymphocytic Leukemia Cells

Roscovitine Prevents Alloreactive T Cell Expansion and TNF-a-Mediated Proinflammatory Gene Expression and Protects against GvHD.

Bidirectional Control of Transcription Factor GATA2 and Cyclin/Cdks in Hematopoietic Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only